Increased levels of MCHR1 in SSc fibroblasts can promote PDGF-BB signaling, increase TGFβ1 and CTGF levels, modulate intracellular cAMP production, and increase the fibrotic response. This evidence concerns the gene CCN2 and systemic sclerosis.